<p>Avantor, Inc. (NYSE:AVTR - 获取免费报告) 的股价在周三交易前跳涨，此前该公司宣布季度收益好于预期。该股此前收于 $7.86，但开盘价为 $8.50。Avantor 的股票最后交易价格为 $7.92，成交量为 2,179,825 股。</p>
<p>该公司报告本季度每股收益为 $0.17，超出分析师一致预期的 $0.16，超出幅度为 $0.01。该公司本季度的收入为 $15.8 亿，而分析师预期为 $15.5 亿。Avantor 的净利润率为 -8.09%，股本回报率为 10.45%。该公司的收入同比增长 0%。在去年同期，该公司每股收益为 $0.23。</p>
<h2>华尔街分析师观点</h2>
<p>几位分析师最近对 AVTR 股票发表了看法。罗伯特·W·贝尔德在 2 月 12 日的研究报告中将 Avantor 的目标价设定为 $11.00。扎克斯研究在 2 月 13 日的研究报告中将 Avantor 的评级从 “持有” 下调至 “强烈卖出”。杰富瑞金融集团在 2 月 12 日的研究报告中重申了 “表现不佳” 的评级，并将 Avantor 的目标价设定为 $8.00。摩根士丹利在 2 月 13 日的报告中将 Avantor 的目标价设定为 $10.00。最后，巴克莱在 4 月 14 日的研究报告中将 Avantor 的目标价从 $8.50 下调至 $7.00，并对该股票给予 “减持” 评级。三位分析师对该股票给予买入评级，九位分析师给予持有评级，三位分析师给予卖出评级。根据 MarketBeat.com 的数据，Avantor 目前的平均评级为 “持有”，共识目标价为 $11.54。</p>
<p><strong>阅读我们最新的 AVTR 股票分析</strong></p>
<h2>Avantor 内部活动</h2>
<p>在相关消息中，董事 Sanjeev K. Mehra 于 3 月 10 日以每股平均 $8.01 的价格购买了 125,000 股公司的股票，总价值为 $1,001,250.00。交易完成后，该董事直接持有 475,000 股公司的股票，价值约为 $3,804,750。这代表了他们持股比例的 35.71% 增加。该收购在向 SEC 提交的文件中披露，文件可通过 SEC 网站访问。此外，董事 Gregory L. Summe 于 2 月 12 日以每股平均 $9.40 的价格购买了 100,000 股 Avantor 股票，总价值为 $940,000.00。收购后，该董事持有 400,000 股公司的股票，价值约为 $3,760,000。这笔交易代表了他们持股比例的 33.33% 增加。关于此次购买的 SEC 文件提供了更多信息。过去 90 天内，内部人士购买了价值 $2,399,250 的 275,000 股公司股票。当前 0.28% 的股票由公司内部人士持有。</p>
<h2>机构资金流入和流出</h2>
<p>几家机构投资者和对冲基金最近买卖了该公司的股票。威灵顿管理集团在第四季度购买了价值约 $268,584,000 的 Avantor 新股份。Greenhaven Associates Inc. 在第三季度购买了价值约 $228,528,000 的 Avantor 新头寸。弗吉尼亚州伦敦公司在第三季度收购了价值约 $159,669,000 的 Avantor 新股份。摩根士丹利在第四季度将其在 Avantor 的持股增加了 179.4%。摩根士丹利目前持有 17,468,418 股公司的股票，价值 $200,188,000，此前在该期间内又收购了 11,216,565 股。最后，挪威银行在第四季度购买了价值 $73,322,000 的 Avantor 新股份。机构投资者目前持有该公司 95.08% 的股票。</p>
<h2>Avantor 股票下跌 0.4%</h2>
<p>该公司的债务与股本比率为 0.70，速动比率为 1.18，流动比率为 1.78。该公司的 50 日简单移动平均线为 $8.19，200 日简单移动平均线为 $10.53。该股票的市值为 $53.4 亿，市盈率为 -10.00，市盈增长比率为 3.13，贝塔值为 1.00。</p>
<h2>关于 Avantor</h2>
<p>(获取免费报告)</p>
<p>Avantor, Inc NYSE: AVTR 是一家全球性公司，向生物制药、医疗保健、教育与政府以及先进技术与应用材料行业的客户提供关键任务产品和服务。该公司提供支持研究、开发、生产和安全应用的基本解决方案。其产品组合涵盖从高纯度化学品和试剂到生物制品和细胞培养基，以及实验室设备、耗材和定制制造服务。</p>
<p>Avantor 的产品按两个主要部门进行组织。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票，胜过 Avantor</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 $1,000 在 Avantor 吗？</h2>
<p>在你考虑 Avantor 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前进行购买……而 Avantor 并不在名单上。</p>
<p>虽然 Avantor 目前在分析师中获得 “持有” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

AVTR

纽交所高增长板生物技术指数 ETF - First Trust

生物科技 ETF - VanEck Vectors

<p>Avantor, Inc.（纽约证券交易所代码：AVTR）在报告季度每股收益为 0.17 美元，超出预期的 0.16 美元后，股价跳涨至 8.50 美元。该公司还报告了 15.8 亿美元的收入，超过了预期的 15.5 亿美元。分析师对该股票的评级不一，普遍目标价为 11.54 美元。近期内部人士的购买表明对公司的信心，而机构投资者持有 95.08% 的股份。尽管收益表现积极，但该股票仍下跌 0.4%，市值为 53.4 亿美元</p>

<p>Avantor, Inc. (NYSE:AVTR - Get Free Report)'s share price gapped up prior to trading on Wednesday after the company announced better than expected quarterly earnings. The stock had previously closed at $7.86, but opened at $8.50. Avantor shares last traded at $7.92, with a volume of 2,179,825 shares trading hands.</p>
<div class="lb-trans"><p>Avantor, Inc. (NYSE:AVTR - 获取免费报告) 的股价在周三交易前跳涨，此前该公司宣布季度收益好于预期。该股此前收于 $7.86，但开盘价为 $8.50。Avantor 的股票最后交易价格为 $7.92，成交量为 2,179,825 股。</p>
</div><p>The company reported $0.17 earnings per share for the quarter, topping analysts' consensus estimates of $0.16 by $0.01. The firm had revenue of $1.58 billion during the quarter, compared to analysts' expectations of $1.55 billion. Avantor had a negative net margin of 8.09% and a positive return on equity of 10.45%. The firm's revenue was up .0% on a year-over-year basis. During the same period in the prior year, the company earned $0.23 EPS.</p>
<div class="lb-trans"><p>该公司报告本季度每股收益为 $0.17，超出分析师一致预期的 $0.16，超出幅度为 $0.01。该公司本季度的收入为 $15.8 亿，而分析师预期为 $15.5 亿。Avantor 的净利润率为 -8.09%，股本回报率为 10.45%。该公司的收入同比增长 0%。在去年同期，该公司每股收益为 $0.23。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><p>Several analysts have recently weighed in on AVTR shares. Robert W. Baird set a $11.00 target price on Avantor in a research note on Thursday, February 12th. Zacks Research cut Avantor from a &#34;hold&#34; rating to a &#34;strong sell&#34; rating in a research note on Friday, February 13th. Jefferies Financial Group restated an &#34;underperform&#34; rating and set a $8.00 price objective on shares of Avantor in a research note on Thursday, February 12th. Morgan Stanley set a $10.00 price objective on Avantor in a report on Friday, February 13th. Finally, Barclays cut their target price on Avantor from $8.50 to $7.00 and set an &#34;underweight&#34; rating on the stock in a research report on Tuesday, April 14th. Three analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the company's stock. According to MarketBeat.com, Avantor presently has an average rating of &#34;Hold&#34; and a consensus price target of $11.54.</p>
<div class="lb-trans"><p>几位分析师最近对 AVTR 股票发表了看法。罗伯特·W·贝尔德在 2 月 12 日的研究报告中将 Avantor 的目标价设定为 $11.00。扎克斯研究在 2 月 13 日的研究报告中将 Avantor 的评级从 “持有” 下调至 “强烈卖出”。杰富瑞金融集团在 2 月 12 日的研究报告中重申了 “表现不佳” 的评级，并将 Avantor 的目标价设定为 $8.00。摩根士丹利在 2 月 13 日的报告中将 Avantor 的目标价设定为 $10.00。最后，巴克莱在 4 月 14 日的研究报告中将 Avantor 的目标价从 $8.50 下调至 $7.00，并对该股票给予 “减持” 评级。三位分析师对该股票给予买入评级，九位分析师给予持有评级，三位分析师给予卖出评级。根据 MarketBeat.com 的数据，Avantor 目前的平均评级为 “持有”，共识目标价为 $11.54。</p>
</div><p><strong>Read Our Latest Stock Analysis on AVTR</strong></p>
<div class="lb-trans"><p><strong>阅读我们最新的 AVTR 股票分析</strong></p>
</div><h2>Insider Activity at Avantor</h2>
<div class="lb-trans"><h2>Avantor 内部活动</h2>
</div><p>In related news, Director Sanjeev K. Mehra bought 125,000 shares of the company's stock in a transaction on Tuesday, March 10th. The shares were purchased at an average cost of $8.01 per share, with a total value of $1,001,250.00. Following the completion of the transaction, the director directly owned 475,000 shares of the company's stock, valued at approximately $3,804,750. This represents a 35.71% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Gregory L. Summe purchased 100,000 shares of Avantor stock in a transaction dated Thursday, February 12th. The shares were purchased at an average cost of $9.40 per share, with a total value of $940,000.00. Following the acquisition, the director owned 400,000 shares of the company's stock, valued at approximately $3,760,000. This trade represents a 33.33% increase in their position. The SEC filing for this purchase provides additional information. Insiders purchased 275,000 shares of company stock worth $2,399,250 in the last 90 days. 0.28% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>在相关消息中，董事 Sanjeev K. Mehra 于 3 月 10 日以每股平均 $8.01 的价格购买了 125,000 股公司的股票，总价值为 $1,001,250.00。交易完成后，该董事直接持有 475,000 股公司的股票，价值约为 $3,804,750。这代表了他们持股比例的 35.71% 增加。该收购在向 SEC 提交的文件中披露，文件可通过 SEC 网站访问。此外，董事 Gregory L. Summe 于 2 月 12 日以每股平均 $9.40 的价格购买了 100,000 股 Avantor 股票，总价值为 $940,000.00。收购后，该董事持有 400,000 股公司的股票，价值约为 $3,760,000。这笔交易代表了他们持股比例的 33.33% 增加。关于此次购买的 SEC 文件提供了更多信息。过去 90 天内，内部人士购买了价值 $2,399,250 的 275,000 股公司股票。当前 0.28% 的股票由公司内部人士持有。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>Several institutional investors and hedge funds have recently bought and sold shares of the company. Wellington Management Group LLP bought a new stake in shares of Avantor during the fourth quarter valued at approximately $268,584,000. Greenhaven Associates Inc. bought a new position in Avantor in the 3rd quarter worth approximately $228,528,000. London Co. of Virginia acquired a new stake in Avantor in the 3rd quarter valued at approximately $159,669,000. Morgan Stanley increased its position in Avantor by 179.4% in the 4th quarter. Morgan Stanley now owns 17,468,418 shares of the company's stock valued at $200,188,000 after acquiring an additional 11,216,565 shares during the period. Finally, Norges Bank bought a new stake in Avantor during the 4th quarter valued at $73,322,000. Institutional investors own 95.08% of the company's stock.</p>
<div class="lb-trans"><p>几家机构投资者和对冲基金最近买卖了该公司的股票。威灵顿管理集团在第四季度购买了价值约 $268,584,000 的 Avantor 新股份。Greenhaven Associates Inc. 在第三季度购买了价值约 $228,528,000 的 Avantor 新头寸。弗吉尼亚州伦敦公司在第三季度收购了价值约 $159,669,000 的 Avantor 新股份。摩根士丹利在第四季度将其在 Avantor 的持股增加了 179.4%。摩根士丹利目前持有 17,468,418 股公司的股票，价值 $200,188,000，此前在该期间内又收购了 11,216,565 股。最后，挪威银行在第四季度购买了价值 $73,322,000 的 Avantor 新股份。机构投资者目前持有该公司 95.08% 的股票。</p>
</div><h2>Avantor Stock Down 0.4%</h2>
<div class="lb-trans"><h2>Avantor 股票下跌 0.4%</h2>
</div><p>The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.18 and a current ratio of 1.78. The firm has a 50 day simple moving average of $8.19 and a two-hundred day simple moving average of $10.53. The stock has a market cap of $5.34 billion, a P/E ratio of -10.00, a P/E/G ratio of 3.13 and a beta of 1.00.</p>
<div class="lb-trans"><p>该公司的债务与股本比率为 0.70，速动比率为 1.18，流动比率为 1.78。该公司的 50 日简单移动平均线为 $8.19，200 日简单移动平均线为 $10.53。该股票的市值为 $53.4 亿，市盈率为 -10.00，市盈增长比率为 3.13，贝塔值为 1.00。</p>
</div><h2>About Avantor</h2>
<div class="lb-trans"><h2>关于 Avantor</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Avantor, Inc NYSE: AVTR is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education &amp; government, and advanced technologies &amp; applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.</p>
<div class="lb-trans"><p>Avantor, Inc NYSE: AVTR 是一家全球性公司，向生物制药、医疗保健、教育与政府以及先进技术与应用材料行业的客户提供关键任务产品和服务。该公司提供支持研究、开发、生产和安全应用的基本解决方案。其产品组合涵盖从高纯度化学品和试剂到生物制品和细胞培养基，以及实验室设备、耗材和定制制造服务。</p>
</div><p>Avantor's offerings are organized across two primary segments.</p>
<div class="lb-trans"><p>Avantor 的产品按两个主要部门进行组织。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Avantor</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Avantor</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Avantor Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 $1,000 在 Avantor 吗？</h2>
</div><p>Before you consider Avantor, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Avantor 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前进行购买……而 Avantor 并不在名单上。</p>
</div><p>While Avantor currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Avantor 目前在分析师中获得 “持有” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Avantor (NYSE:AVTR) Shares Gap Up  on Strong Earnings

Market Beat

Avantor

美国医药设备 ETF - iShares

标普生物技术 3 倍做多 - Direxion

2 倍做多纳斯达克生物技术 ETF - ProShares

动态生物技术与基因组 ETF - Invesco

标普健康医疗设备 ETF - SPDR

标普生物技术 ETF - SPDR

纳斯达克生物科技指数 ETF - iShares Nasdaq

医药突破 ETF - ALPS

Jefferies Financial

摩根士丹利

巴克莱银行

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

Avantor（纽交所代码：AVTR）因强劲的业绩而股价跳空高开